T2 Biosystems pulls in $40M in Series E funding round

03/29/2013 | American City Business Journals

A Series E funding round led by Goldman Sachs has brought in $40 million for T2 Biosystems. The Lexington, Mass.-based company will use the money to develop and commercialize its T2Candida test, which can detect Candida fungal infections known to cause sepsis from whole blood samples in under two hours.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD